Channel Therapeutics Corpora
13F holders, Q2 2025 (June 30)5holders −4
1new positions
5sold out
1famous investor
$1.27avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Channel Therapeutics Corpora in their 13F filings, down 4 from Q1 2025. 1 opened new positions and 5 sold out. The largest holders were Millennium Management ($172K), Geode Capital Management, LLC ($14K) and UBS Group AG ($822). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Channel Therapeutics Corpora
- CUSIP
- 171126105
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $172K |
| Exits | 5 | $827K |
All 13F filers, Q1 2025 → Q2 2025: 137,084 shares bought and 585,080 shares sold, net −447,996 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Millennium Management | 0.00% | New | 136,712 | $172K |
| Geode Capital Management, LLC | 0.00% | Add +3.6% | 10,435 | $14K |
| UBS Group AG | 0.00% | Reduce -34.5% | 652 | $822 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -96.7% | 85 | $107 |
| Bank of America Corp. | 0.00% | Add +58.3% | 19 | $24 |
"% of holder's portfolio" is CHANNEL THERAPEUTICS CORPORA's weight in each manager's 13F, not the share of Channel Therapeutics Corpora the manager owns.